A mid-sized pharmaceutical company was building a new R&D and manufacturing facility in Western India. The site would hold research laboratories, controlled material stores, production areas and data systems containing sensitive intellectual property.
Construction was well underway, but security had been treated mainly as an equipment purchase. The MEP consultant, the IT team and a systems integrator had each specified parts of the security infrastructure, often using templates from earlier projects.
Leadership wanted assurance that the facility would meet regulatory, insurance and client audit expectations from day one. They also wanted to avoid spending on systems that looked comprehensive on paper but wouldn't protect what mattered most.